- ¥129bn
- ¥318bn
- ¥364bn
Table: Phc Holdings -9-MTH group results (IFRS)
Table: Phc Holdings 6-MTH group results (IFRS)
Brief: PHC Holdings Corp - Notice Regarding Signing Of Memorandum Of Understanding On Business Transfer Of A Consolidated Subsidiary
Table: Phc Holdings -Q1 group results (IFRS)
Table: Phc Holdings -2024/25 group results (IFRS)
Table: Phc Holdings -2024/25 group results (IFRS)
Brief: Epredia Receives U.S. FDA 510(K) Clearance For The E1000 DX™ Digital Pathology Solution
Table: Phc Holdings -9-MTH group results (IFRS)
Table: Phc Holdings 6-MTH group results (IFRS)
Table: Phc Holdings -Q1 group results (IFRS)
Table: Phc Holdings -2023/24 group results (IFRS)
Table: Phc Holdings -2023/24 group forecast(IFRS)
Table: Phc Holdings -2023/24 div forecast
Brief: Eversense CGM System Receives ICGM Designation By The Us FDA
Table: Phc Holdings -9-MTH group results (IFRS)
Table: Phc Holdings -6-MTH group results (IFRS)
Table: Phc Holdings -Q1 group results (IFRS)
Table: Phc Holdings -2022/23 group results (IFRS)
Table: Phc Holdings -2022/23 group forecast(IFRS)